ANTHRACYCLINE-REFRACTORY TNBC

Clinical trials for ANTHRACYCLINE-REFRACTORY TNBC explained in plain language.

Never miss a new study

Get alerted when new ANTHRACYCLINE-REFRACTORY TNBC trials appear

Sign up with your email to follow new studies for ANTHRACYCLINE-REFRACTORY TNBC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

Gene therapy added to cancer fight for toughest breast tumors

Disease control Terminated

This study tested whether adding a gene therapy to standard chemotherapy and immunotherapy could help shrink tumors in people with triple-negative breast cancer that hadn't responded to previous treatment. The approach aimed to boost the immune system's ability to attack cancer c…

Matched conditions: ANTHRACYCLINE-REFRACTORY TNBC

Phase: PHASE2 • Sponsor: The Methodist Hospital Research Institute • Aim: Disease control

Last updated Apr 02, 2026 09:12 UTC

ANTHRACYCLINE-REFRACTORY TNBC

Get alerted when new ANTHRACYCLINE-REFRACTORY TNBC trials appear

Gene therapy added to cancer fight for toughest breast tumors